Systemic interleukin 10 levels indicate advanced stages while interleukin 17A levels correlate with reduced survival in esophageal adenocarcinomas.

Karl-Frederick KarstensJan KempskiAnastasios D GiannouErik FreiwaldMatthias ReehMichael TachezyJakob R IzbickiAnsgar W LohseNicola GaglianiSamuel HuberPenelope Pelczar

Published in: PloS one (2020)

Systemic IL-6 levels are increased, while IL-17A levels are reduced in EAC patients compared to healthy controls. In addition, circulating IL-10 might help to identify patients with advanced disease and high IL-17A might indicate a limited prognosis.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors